abstract |
HBV replication inhibitors with formula (I) Included are their stereochemically isomeric forms, as well as salts, hydrates, solvates, wherein B, R 1 , R 2 and R 4 have the meanings as defined herein. The invention also relates to processes for the preparation of said compounds, pharmaceutical compositions comprising them and their use alone or in combination with other HBV inhibitors in HBV therapy. |